FindTrial
Sign In

Donepezil HCl

DRUG7 trials

Sponsors

University of Pittsburgh, University Health Network, Toronto, Eisai Inc., Eisai Co., Ltd., The Cleveland Clinic

Conditions

Alzheimer's DiseaseAutistic DisorderDementia Associated With Cerebrovascular DiseaseDown SyndromeEnd-Stage Renal DiseaseGenetic Risk for Alzheimer's DiseaseMild to Severe Alzheimer's Disease

Phase 2

Donepezil HCl & Cognitive Deficits in Autism
CompletedNCT00047697
University of PittsburghAutistic Disorder
Start: 2002-10-31End: 2006-08-31Updated: 2017-10-05
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
CompletedNCT00570128
Eisai Inc.Down Syndrome
Start: 2007-11-16End: 2008-09-05Updated: 2021-04-19

Phase 3

Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
CompletedNCT00188812
University Health Network, TorontoDementia Associated With Cerebrovascular Disease
Start: 2004-05-31End: 2005-08-31Updated: 2009-01-12

Phase 4

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
CompletedNCT00571064
Eisai Inc.Mild to Severe Alzheimer's Disease
Start: 2008-01-31End: 2009-04-22Updated: 2018-09-27
Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
CompletedNCT01063556
Eisai Co., Ltd.End-Stage Renal Disease
Start: 2010-02-28End: 2010-03-31Updated: 2013-05-14
Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease
CompletedNCT02087865
The Cleveland ClinicGenetic Risk for Alzheimer's Disease
Start: 2014-05-31End: 2021-12-20Updated: 2023-08-30
Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
CompletedNCT02097056
Eisai Korea Inc.Alzheimer's Disease
Start: 2014-02-28End: 2015-05-31Updated: 2016-06-27